Acutus Medical Inc (AFIB) - Total Assets
Based on the latest financial reports, Acutus Medical Inc (AFIB) holds total assets worth $28.65 Million USD as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AFIB net asset quality index to measure how much of total assets are equity-financed.
Acutus Medical Inc - Total Assets Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's total assets have evolved over time, based on quarterly financial data. Explore Acutus Medical Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Acutus Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Acutus Medical Inc's total assets of $28.65 Million consist of 89.3% current assets and 10.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 48.9% |
| Accounts Receivable | $7.88 Million | 27.5% |
| Inventory | $1.79 Million | 6.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Acutus Medical Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Acutus Medical Inc's current assets represent 89.3% of total assets in 2024, an increase from 84.6% in 2018.
- Cash Position: Cash and equivalents constituted 48.9% of total assets in 2024, up from 37.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 27.5% of total assets.
Acutus Medical Inc Competitors by Total Assets
Key competitors of Acutus Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Acutus Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 2.44 | 2.55 |
| Quick Ratio | 1.91 | 2.22 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $13.14 Million | $27.31 Million | $38.36 Million |
Acutus Medical Inc - Advanced Valuation Insights
This section examines the relationship between Acutus Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.16 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -46.9% |
| Total Assets | $28.65 Million |
| Market Capitalization | $903.35K USD |
Valuation Analysis
Below Book Valuation: The market values Acutus Medical Inc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Acutus Medical Inc's assets decreased by 46.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Acutus Medical Inc (2018–2024)
The table below shows the annual total assets of Acutus Medical Inc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $28.65 Million | -46.91% |
| 2023-12-31 | $53.96 Million | -59.56% |
| 2022-12-31 | $133.44 Million | -21.41% |
| 2021-12-31 | $169.79 Million | -11.81% |
| 2020-12-31 | $192.53 Million | +82.58% |
| 2019-12-31 | $105.45 Million | +306.41% |
| 2018-12-31 | $25.95 Million | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more